Journal of Rheumatology - McMaster Experts

publication venue for

Choosing Wisely: The Canadian Rheumatology Association Pediatric Committee’s List of Items Physicians and Patients Should Question 2023
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis 2023
Cluster Analysis To Explore Clinical Subphenotypes Of Eosinophilic Granulomatosis With Polyangiitis (Churg–Strauss) 2023
Characteristics of Relapse of Individuals With ANCA-Associated Vasculitis Enrolled in the PEXIVAS Trial 2023
Machine Learning Analysis of Sporadic Inclusion Body Myositis Biomarkers 2023
Retention of Triple Therapy With Methotrexate, Sulfasalazine, and Hydroxychloroquine Compared to Combination Methotrexate and Leflunomide in Rheumatoid Arthritis, a Real-World Data From the Ontario Best Practices Research Initiative 2023
The Effects of Initial Treatment on Relapse of ANCA-Associated Vasculitis in the PEXIVAS Trial 2023
A Case of Rhabdomyolysis Following Vaccination Against COVID-19 in a Patient With Pathogenic Ryanodine Receptor Gene Variant 2022
An Unusual Presentation of Granulomatosis With Polyangiitis in a Pediatric Patient 2022
Health Information Use by SLE Patients Pre and During COVID-19 2022
Investigating the Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample 2022
Ocular Manifestations of ANCA-associated Vasculitis 2022
Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis 2022
Transient Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: A Precursor to Giant Cell Arteritis? 2022
Transition Us Together: Development of a Parent-Centered Toolkit to Support Adolescents With Rheumatic Disease Transition to Adult Care 2022
Variations in Pediatric Rheumatology Workforce and Care Processes Across Canada 2022
A Review of PAH Screening Practices of Patients in the Canadian Scleroderma Research Group Registry: Is It Time to Revise the Guidelines? 2021
Antimalarial Drug Shortages During the COVID-19 Pandemic: Results From the Global Rheumatology Alliance Patient Experience Survey 2021
Changes in Disease Features Do Not Differ Between SSc Patients Who Did versus Did Not Undergo Annual PAH Screening: Data from the Canadian Scleroderma Research Group Registry 2021
Characteristics of Adult Patients With Rheumatic Diseases During the COVID-19 Pandemic: Data from an International Patient Survey 2021
Impact of the COVID-19 Pandemic Among Children With Rheumatic Diseases from Around the Globe 2021
Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed With Rheumatic Diseases 2021
Improvements in Transition Readiness in Adolescents With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus 2021
Investigating SLE Patients' Access to Health Information Pre and During the COVID-19 Pandemic 2021
Late Cardiovascular Outcomes in Children With Kawasaki Disease: A Population-based Cohort Study 2021
Long-term Hearing and Neurodevelopmental Outcomes Following Kawasaki Disease: A Population-based Cohort Study 2021
Medical Cannabis Use in Patients Attending Rheumatology Clinics in Ontario 2021
Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients With Rheumatic Disease 2021
Placental Fibrin Deposition and Thrombosis Leading to Intrauterine Growth Restriction: A Case Report of a Young Woman With Eosinophilic Fasciitis 2021
Radiological Validation of a Novel MRI Reporting System for Axial Spondyloarthritis 2021
The Fecal Microbiome Differences Between Patients With Systemic Sclerosis With And Without Small Intestinal Bacterial Overgrowth 2021
Vasculitis in Patients With Rheumatoid Arthritis: A Descriptive Study 2021
A Canadian Evaluation Framework for Quality Improvement in Childhood Arthritis: Key Performance Indicators of the Process of Care 2020
A Serum Proteomic Signature Defines Transition From the Preclinical State to Rheumatoid Arthritis 2020
Biopsy-positive Versus Negative Giant Cell Arteritis: Clinical Presentation, Predictive Factors and Effect of Extra-long Biopsy Length 2020
Comparison between Patients with Spondyloarthritis Managed in Community Based Care Settings to those Managed in Tertiary Research Setting in Ontario: An OBRI-SPARCC Study 2020
Development of a Patient-Centred Iloprost and Alprostadil Infusion Information Sheet for Patients with Scleroderma 2020
Elevation of Platelet Factor 4 in Systemic Sclerosis 2020
Inter-Rater Reliability of the Bhavsar-Khalidi Clinical Scoring System for Risk Stratification of Giant Cell Arteritis 2020
Kawasaki Disease in Ontario Children From 1995-2017: A Population-based Descriptive Analysis 2020
Pituitary Disease in Granulomatosis with Polyangiitis: An International Collaborative Case Series 2020
Prevalence and Predictors of Depression among Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Canadian Real World Observational Cohort: Results from the COMPLETE Studies 2020
Prevalence of Work Disability and Predictors of Work Productivity among Employable Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Canadian Real World Observational Cohort: Interim Results from the COMPLETE Studies 2020
Pulmonary Arterial Hypertension Screening Practices in Scleroderma Patients Amongst Canadian Rheumatologists 2020
Rationalizing Temporal Artery Magnetic Resonance Angiography in the Diagnosis of Giant Cell Arteritis 2020
Rheumatologist Survey on Medical Cannabis: Results from the Ontario Best Practices Research Initiative: (OBRI) 2020
Sacroiliitis and Spondyloarthritis in Patients with Giant Cell Arteritis - More than a Chance Occurrence 2020
The Effect of Pregnancy on the Progression of Scleroderma 2020
Transition From Pediatric to Adult Rheumatology: The Clinician as a Fundamental Ally 2020
Anakinra Exposure in a Pregnant Patient with Juvenile Idiopathic Arthritis: A Case Report 2019
Assessing Perceptions, Barriers and Preferences to Exercise in Patients with Systemic Lupus Erythematosus 2019
Clinical Swelling in the Feet May Not Accurately Represent Active Inflammation in Patients with Rheumatoid Arthritis 2019
Effectiveness and Safety of Infliximab in Ankylosing Spondylitis: A Multi-Centre, Prospective, Observational Study from the Biologic Treatment Registry Across Canada (BioTRAC) 2019
Long-Term Effectiveness and Safety of Infliximab in Rheumatoid Arthritis Patients: Real-World Data from the Biologic Treatment Registry Across Canada (BioTRAC) 2019
Longitudinal Changes in Relative Market Share Proportions of Biologic, and Targeted Synthetic, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for Treatment of Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (OBRI) 2019
No Evidence for an Increased Risk of Infection in Newborns and Postpartum Mothers after Exposure to Biologics in the Third Trimester: A Single Center Observational Cohort Study 2019
Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care 2019
Ready or Not: Transition Readiness in JIA and SLE 2019
Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care 2019
Scleroderma and Pregnancy: Worse Pulmonary Outcomes Following Pregnancy in Patients from the CSRG Registry 2019
Severe Ischemic Events in Takayasu Arteritis: A Canadian Retrospective Cohort 2019
Sub-Clinical Disease Activity in the Feet of Patients with Early Rheumatoid Arthritis: What Clinical Assessments Miss 2019
TNF Inhibitor Dose Tapering in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis 2019
The RA BIODAM Study: Prospective Validation of Soluble Biomarkers as Predictors of Structural Damage in Rheumatoid Arthritis 2019
The Trajectory of Grade 1 Erosions in the Feet of Patients with Early RA 2019
Ultrasound Detects Subclinical Inflammation in the Hands and Feet of Patients with Rheumatoid Arthritis in CDAI Remission 2019
YouTube as a Platform for Narrative Medicine: A Novel Approach to Promote Empathy and Awareness for Patients with Chronic Disease 2019
Assessing the Educational Needs of Canadians with Systemic Sclerosis 2019
Biopsy-positive versus Negative Giant Cell Arteritis: Clinic Presentation and Predictive Factors 2018
Central Reader Assessment of Imaging in Axial Spondyloarthritis: What is the Potential Impact on the Performance of the ASAS Classification Criteria? 2018
Diagnostic Ascertainment of Axial Spondyloarthritis in Patients Presenting with Undiagnosed Back Pain: What is the Impact of MRI in Rheumatological Practice? 2018
Disparities between Ultrasound and MRI Assessment of Erosions: Are they Dependent on Size and Location? 2018
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening over the 6 Weeks using a Randomised Controlled Open-label Trial?: "One good thing about music, when it hits, you feel no pain" 2018
Economic Evaluation of Damage Accrual in a Nationwide Canadian SLE Cohort 2018
Efficacy of Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis: A Meta-analysis and Systematic Review 2018
Factors Affecting Consideration of a Career in Rheumatology by Internal Medicine Residents 2018
Improvement in Work Productivity and Fatigue of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study 2018
Improvements in Bone Marrow Edema, Erosions, and Synovitis of the Feet in Early Rheumatoid Arthritis 2018
Incidence of Extra-Articular Manifestations in PsA and AS Patients Treated with Golimumab in Canadian Real-World 2018
Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry 2018
Is Earlier Golimumab Treatment Initiation in PsA and AS Patients Associated with Improved Outcomes? 2018
Is Pressure Distribution in the Feet Associated with Imaging Evidence of Disease Activity in Patients with Early Rheumatoid Arthritis? 2018
Knowledge Translation in Juvenile Idiopathic Arthritis Research in Canada: Comparing and Contrasting Parent and Adolescent Perceptions 2018
Pancreatitis as the Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Review of the Literature 2018
Predictors of Long-Term Retention of Methotrexate and Other DMARDs with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry 2018
Pressure Distribution in the Feet of Patients with Early Rheumatoid Arthritis: Is it Related to Clinical Symptoms or Patient-Reported Outcomes? 2018
Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period 2018
Systematic Review of Randomized Controlled Trials Assessing Efficacy and Safety of Hydroxychloroquine in Systemic Lupus Erythematosus 2018
The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study 2018
Ultrasound Finds Discordance between Disease Activity in the Hands and Feet of Patients with Rheumatoid Arthritis 2018
Use of a Clinical Scoring System in Risk Stratifying Patients with Suspected Giant Cell Arteritis 2018
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting 2018
"Going Down a Different Path": A Qualitative Exploration of Costs Incurred by Patients with Systemic Lupus Erythematosus 2017
A Case Series of Two Presentations of Skull Base Inflammatory Pseudotumor Sparing the Orbit and a Review of the Literature Focusing on Steroids and Immunosuppressive Induction Regimens 2017
A Needs-based Rheumatologist Education Program on Treating to Target in Psoriatic Arthritis and Spondylarthropathy: Insights, Challenges, and Future Directions 2017
Assessing the Correlation between Early Erosions in Rheumatoid Arthritis (EERA) Software and the EULAR-OMERACT Rheumatoid Arthritis Scoring System (RAMRIS) for Quantifying Erosions in the MTP Joints of Patients with Early RA 2017
Assessing the Reliability of Early Erosions in Rheumatoid Arthritis (EERA) Software for Quantifying Erosions in the Metatarsophalangeal (MTP) Joints of Patients with Early Rheumatoid Arthritis (RA) 2017
Automated Data Extraction from Electronic Medical Records in Rheumatology: An Ontario Best Practices Research Initiative Pilot Project (OBRI) 2017
Canadian Study of Outcomes in Adalimumab Patients with Support for Adherence: Results from the COMPANION Study 2017
Comparison of Baseline Characteristics of Psoriatic Arthritis Patients Initiating Therapy with Subcutaneous Golimumab or Ustekinumab: An Analysis from a Prospective, Observational Registry 2017
Do Specific Entheseal Points in SpA Patients Impact Patient Reported Outcomes? Implications for Clinical Practice 2017
Effect of Personalized Diet and Exercise Recommendations in Early Inflammatory Arthritis: A Randomized Trial 2017
Human Resources Committee's Subgroup-interpretation of Student Recruitment Activities 2017
Impact of Concomitant Use of Disease Modifying Antirheumatic Drugs and Methotrexate Administration Route on Durability of Biologic Treatment: Results from the Ontario Best Practice Research Initiative (OBRI) Cohort 2017
Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-world Setting 2017
Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy 2017
Predictors of Canadian Adult Rheumatologist Clinical Workload and Working Hours 2017
Predictors of Golimumab Retention among Patients with Rheumatoid Arthritis on Stable Treatment in Canadian Real-world Setting 2017
Presence and Frequency of Power Doppler Signals are Associated with Higher Leeds Foot Impact Scale Scores in Early Rheumatoid Arthritis Patients 2017
Pulmonary Arterial Hypertension and Pulmonary Fibrosis Screening in Systemic Sclerosis in Clinical Practice: Choosing Wisely or Missed Opportunities? 2017
Pulseless in Periphery: A Case of AL Amyloidosis Mimicking Large Vessel Vasculitis 2017
Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada 2017
Strongyloides Presenting as Diffuse Alveolar Hemorrhage in SLE: A Case Report 2017
The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis 2017
The Rationale for Using a Composite Score when Designing Future Randomized Controlled Trials in the Post-menopausal Osteoporisis Population: A Systematic Review 2017
Understanding the Impact of Early Rheumatoid Arthritis on the Feet: Pain, Activity Limitations, and General Health 2017
Which Criteria for Inflammatory Back Pain in Spondyloarthritis are Optimal? Data from the Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Study (SASPIC) 2017
#MakeRheum for Rheumatology: Testing Novel Ways to Increase Interest in Rheumatology by Canadian Undergraduate and Postgraduate Medical Trainees 2016
A Longitudinal Pilot Study Investigating Changes in Metacarpophalangeal Erosive Damage and Functional Ability in Patients with Rheumatoid Arthritis Using Magnetic Resonance Imaging and Computerized Segmentation 2016
Adherence to a Treat-To-Target Strategy is Key to Attainment of Sustained Remission in Rheumatoid Arthritis: Data from the Real-world Practice BIODAM Cohort 2016
Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study 2016
First Presentation of Inflammatory Bowel Disease as a Migratory Polyarthritis with Positive C-ANCA and PR3 2016
Giant Cell Arteritis Presenting with Bilateral Vertebral Artery Stenosis - A Case Report and Review of the Literature 2016
Impact of MRI on Diagnostic Reclassification in Axial Spondyloarthritis: Data from the Screening for Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Study (SASPIC) 2016
Is Treat-To-Target Really Working? A Longitudinal Analysis in BIODAM 2016
Knee Pain Intensity is Associated with Muscle Adiposity in the Whole Thigh and Hamstrings of Women with Knee Osteoarthritis 2016
Leukotriene Receptor Antagonist Therapy Associated Eosinophilic Granulomatosis with Polyangiitis: A Case and Literature Review 2016
Measuring the Rheumatologist Workforce in Canada: Stand Up and Be Counted! 2016
No Escalation of Therapy Despite High Disease Activity in the CATCH Cohort 2016
No Sex Bias in the Escalation of Therapy in the Treatment of Early Inflammatory Arthritis 2016
Nurse-led Care for Patients with Rheumatoid Arthritis: A Systematic Review 2016
Ophthalmoplegia - An Unusual Presentation of GCA 2016
Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort 2016
Poor Agreement between Clinical Swelling and Ultrasound-Detected Synovial Thickening in Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis 2016
Process Evaluation of "Employment & Arthritis: Making it Work", An Online Program to Help People with Inflammatory Arthritis Maintain Employment 2016
Proof of Concept Study of the Arthritis Health Journal: An Online Tool to Promote Self-Monitoring in People with Rheumatoid Arthritis (RA) 2016
Recurrence of Scleroderma Renal Crisis in Transplanted Kidney Leading to Graft Failure 2016
Reliability Analysis of Two Short Medication Adherence Questionnaires in Patients with Rheumatoid Arthritis 2016
Ribbing's Disease Compared to Intramedullary Osteosclerosis: A Case Presentation 2016
Understanding Erosions Inside-Out: Erosion Depth Predicts Bone Repair over 2 Years in Rheumatoid Arthritis 2016
Assessing the Agreement of Patient Self-assessed Joint Count and Rheumatologist Joint Count Assessments in Patients with Inflammatory Arthritis: A Method Comparison Study 2015
Developing System Level Performance Measures for Evaluating Models of Care for Inflammatory Arthritis 2015
Does Treatment Improve HAQ or Do Patients Adjust How They Do Things? An Exploration of the HAQ-DI vs the HAQ-ADI over Time 2015
Early Erosions in Rheumatoid Arthritis (EERA) Software Reliably Measures Erosive Damage on MRI in the Metacarpophalangeal Joints of Rheumatoid Arthritis Patients 2015
Educating Rheumatologists May Lead to Measuring More Disease Parameters and Treating to a Target in Psoriatic Arthritis and Spondyloarthropathy. Results from the Metrix II Study 2015
Foot Imaging Study - Ultrasound is better than Clinical Exam at Detecting Synovitis 2015
Improvements in Bone Mineral Density and Health Related Quality of Life Maintained in Patients Treated with Teriparatide 2015
Inflammatory Pseudotumour of the Skull Base: A Case Report and Review of the Literature 2015
Non-adherence to Treat-to-Target of Rheumatoid Arthritis in The International RA BIODAM Program: What Defines this Population? 2015
Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting 2015
Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab in Canada 2015
Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study 2015
Rheumatoid Arthritis Presenting with Acute Interstitial Pneumonitis Manifesting before Arthritis, a Rare and Atypical Presentation. A Case Report 2015
Survey of Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada 2015
Systematic Review of Therapeutic Plasma Exchange for the Treatment of Catastrophic Antiphospholipid Antibody Syndrome 2015
T Cell Epitopes Stimulating TGF beta in Patients with Systemic Sclerosis: Towards a Vaccine 2015
The Efficacy and Safety of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA at Week 97 (SUMMACTA) 2015
The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study 2015
Training the Rheumatologists of Tomorrow: The Learners Experience 2015
Training the Rheumatologists of Tomorrow: The WOMAC Experience 2015
Using Patient Reported Outcome Measures to Classify Disease Activity States in Rheumatoid Arthritis: A Comparison of Patient Activity Score (PAS) and Routine Assessment of Patient Index Data (RAPID) 2015
Using Patient Reported Outcome Measures to Classify Disease Activity States in Rheumatoid Arthritis: A Comparison of Patient-Derived Versions of Clinical Disease Activity Index, Simplified Disease Activity Index, and Disease Activity Score 28 2015
Vasculitis in Patients with Inflammatory Bowel Diseases: A Study of 32 Patients and Systematic Review of the Literature 2015
A Case of Multiple Myeloma Presenting as Polyarthritis and Cutaneous Vasculitis 2014
Anti-RNA Polymerase III Antibodies in the Diagnosis of Scleroderma Renal Crisis Sine Scleroderma 2014
Are there Gender Specific Differences in Patient Reported Outcomes at Initiation of Golimumab Treatment in Rheumatoid Arthritis? 2014
Can People with Rheumatoid Arthritis Self Monitor their Disease Activity? 2014
Can Satisfactory Reliability of the 7-Joint Ultrasound Score be Attained by Inexperienced Readers in a Single Calibration Exercise? Results from the BIODAM Program 2014
Correlation of Individual HAQ Questions with Outcome Measures in Rheumatoid Arthritis: Implications for Instrument Reduction 2014
Corticosteroid Use in Rheumatoid Arthritis Patients on Infliximab: Treatment Implications and Impact on Durability of Response Based on a Real-World Canadian Population 2014
Development and Usability Testing of the Arthritis Health Journal: An Online Tool to Promote Self-Monitoring with Rheumatoid Arthritis 2014
Does Specific Joint Involvement in Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications for Clinical Practice 2014
Empirical Treatment of Dermatomyositis with Intravenous Immunoglobulin in Pregnant Patient 2014
How does Non-Compliance to Prolia (R) (Denosumab) Affect the Change in Bone Mineral Density (BMD)? 2014
Impact of Adherence to Treat-to-Target of Rheumatoid Arthritis in Real World Practice: Data from the International RA BIODAM Program 2014
Multicenter Validation of the Lupus Activity Scoring Tool (LAST) as Compared to the SELENA SLEDAI (SS) Modification 2014
New Onset Dermatomyositis in Pregnancy: A Case Report and Review of the Literature 2014
Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC 2014
Pseudohypoparathyroidism ... a Possible Insight into the Pathophysiology of Ankylosing Spondylitis 2014
Rheumatologists of Tomorrow: One School's Story 2014
Staphylococcus Aureus Infection following Facet Joint Injection Masquerading as Acute Polyarthritis and Polymyalgia Rheumatica 2014
The Validation of Administrative Osteoarthritis Diagnosis using a Clinical and Radiological Population-Based Cohort from British Columbia, Canada 2014
Use of an Online Questionnaire to Disseminate CRA Guidelines for RA Management 2014
Variability in Patient Characteristics and Outcomes in Rheumatoid Arthritis upon Infliximab Treatment Based on the Size of Biologic Treatment Registry Site 2014
Variability in the Classification of Remission Among Disease Activity Indices and their Correlation: An Analysis from a Prospective, Observational Registry 2014
A Retrospective Study to Evaluate the Effectiveness, Drug Survival, and Safety of Golimumab in Rheumatoid Arthritis Patients in Canadian Rheumatology Practice 2013
A Retrospective Study to Evaluate the Effectiveness, Safety and Drug Survival of Tocilizumab in Rheumatoid Arthritis Patients in a Single Hamilton Practice 2013
A Retrospective Study to Evaluate the Safety, Efficacy, and Drug Survival of Rituximab in Rheumatoid Arthritis Patients in a Single Canadian Practice 2013
All Cause Hospitalizations in Systemic Lupus Erythematosus from a Large Referral Center Demonstrate More Intensive Care and Longer Length of Stay 2013
Are Needs Being Addressed? Mapping the Evolution of Canadian Rheumatologists' Gaps and Challenges in the Last Decade 2013
Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center 2013
Certolizumab Pegol Improves Productivity at Paid Work and within the Household in Adult Rheumatoid Arthritis Patients in Daily Practice in Canada: Interim Analysis of the Observational Noninterventional FasT CAN Study 2013
Corticosteroid use in Rheumatoid Arthritis Patients Taking Infliximab: Treatment Implications Based on a Real-world Canadian Population 2013
Dyspnea in Pregnancy Secondary to an Atrial Mass in a Patient with Antiphospholipid Syndrome 2013
Efficacy of Denosumab after Implementation of Charlton Patient Advocacy Program 2013
First Report of Golimumab Real-World Effectiveness in Low/Moderate and High Disease Activity in Patients with Rheumatoid Arthritis 2013
Golimumab Start-Stop: Drug Discontinuation due to Financial Constraints; Experience from a Single Hamilton Center 2013
IgG4-related Hypertrophic Pachymeningitis: A Case Report 2013
Longterm Safety of Rituximab in Rheumatoid Arthritis Clinical Trials: A 10-Year Followup Study 2013
Methodological Reporting of Clinical Trials in Lupus Cochrane Reviews 2013
Optimal Care of Rheumatoid Arthritis and Spondyloarthropathies: A Road Going Through Enhanced Collaboration and Communication for Canadian Rheumatologists 2013
Reliability of the Early Erosions in Rheumatoid Arthritis Software when Quantifying Bone Loss 2013
Safety and Effectiveness of TNF-Alpha Inhibitor Therapy with Certolizumab Pegol Observed in Daily Practice in Adult Rheumatoid Arthritis Patients in Canada - First Interim Analysis of the Noninterventional FasT CAN Study 2013
TEAM-Managed Care of Biological Patients at a Canadian Centre 2013
Validation of SNAPSHOT (c) (TM) As a Rheumatoid Arthritis Clinical Assessment Tool 2013
Vitamin D in Obesity (VIDeO): Assessing Vitamin D Deficiency in the Bariatric Population, a Quality Assurance Initiative 2013
A Case Report of Hemophagocytic Syndrome in a Patient with Dermatomyositis 2012
Clinical and Serological Correlates of Systemic Sclerosis Sine Scleroderma: Findings from a Canadian Cohort 2012
Distinct Phenotypical Clusters in Childhood Inflammatory Brain Diseases: Implications for Diagnostic Evaluation 2012
Five-year Incident Fracture Risk Assessed by Quantitative Multisite Ultrasound: The Canadian Multicentre Osteoporosis Study 2012
On-line Case Simulation Versus Paper Format: The Ability to Screen for Arthritis Using GALS 2012
On-line vs Paper Format Learning: Identifying Inflammatory Arthritis Early: Randomized Control Trial 2012
Rates and Causes of Hospitalizations in Systemic Lupus Erythematosus in London, Ontario over 3.5 Years 2012
The Gait, Arms, Legs & Spine (GALS) Exam: An Effective Screening Tool for Rheumatoid Arthritis When Used by Family Physicians and Nurse Practitioners 2012
The Risk of Developing Cardiovascular Diseases among Osteoarthritis Patients: A Prospective Study 2012
Amyloidosis and GCA/PMR: Case Report of a Rare Association 2011
Assessing the Rate of Serious Infections in Rheumatoid Arthritis (RA) Patients who Receive Other Biologic Therapies after Discontinuing Rituximab (RTX) 2011
Characteristics of Hospitalizations of Patients with Systemic Lupus Erythematosus: A retrospective study from London, Ontario 2011
Demyelinating events in Seniors with Rheumatoid Arthritis (RA): A Population-based Study 2011
Disease Activity in Patients Prescribed Biologics in Ontario: Results from the OBRI 2011
Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries 2011
Intra-rater reliability of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI) in Children with Spondyloarthritis 2011
Panniculitis/Fasciitis due to a Drug-Induced Neutrophilic Dermatosis: A case report 2011
Safety Analysis of Tocilizumab (TCZ) in Rheumatoid Arthritis (RA) Patients (pts): Long-Term Extension Studies (Median of 3.1 Years of Treatment) 2011
The Incidence of Herpes Zoster in Seniors with Rheumatoid Arthritis: A Population-Based Study 2011
Assessing the Practice and Attitudes of Nursing Staff in Long Term Care (LTC) Facilities Related to Osteoporosis Awareness, Management and Fracture Prevention 2010
BMD Shows Osteoporosis in only 25% of Males with Known Fragility Fracture, Resulting in Significant Under-Treatment and Fracture Protection 2010
Back to the Bedside - A Case of Systemic Lupus Erythematosus Associated with pANCA, cANCA and Anti-Scl Antibodies - Distilling the Diagnostic Dilemma and Literature Review 2010
Baseline Characteristics and Preliminary Efficacy Results of Patients Receiving Biologic and Traditional Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Ontario: Results from the OBRI 2010
Case Series: Atypical Fractures of the Femoral Diaphysis in Patients on Long Term Bisphosphonate Therapy 2010
Development Of The 2009 Revised ACR Recommendations For The Management Of Osteoarthritis 2010
Giant Cell Arteritis and MRI Evaluation of the Cranial Arteries 2010
Incidence and Predictors of Hospitalization of Patients with Systemic Lupus Erythematosus 2010
Nailfold Capillaroscopy in Juvenile Dermatomyositis: Correlation with Flow Mediated Vasodilatation 2010
Patient Self Reported Health Related Quality of Life Improves with Effective Treatment in Early Inflammatory Arthritis (EIA) 2010
Predictors of Hip Disease in the Systemic Arthritis Subtype of Juvenile Idiopathic Arthritis 2010
Proximal Muscle Weakness and Statin Use: A Case of Mistaken Identity 2010
Resolution of Osteonecrosis of the Jaw after Teriparatide [Recombinant Human PTH-(1-34)] Therapy 2010
Rheumatoid Arthritis(RA) and Risk of Serious Infections: A Nested Case-Control Study from the Ontario Biologics Research Initiative 2010
Serious Fungal Infections in Seniors with Rheumatoid Arthritis(RA): A Population-based Study from the Ontario Biologics Research Initiative 2010
Temporal Artery Biopsy... Does Length Really Matter? 2010
The Sensitivity and Specificity of the GALS (Gait, Arms, Legs, Spine) Examination when used by Physiotherapists to Detect Rheumatoid Arthritis 2010
Ultrasonographic Assessment of Cartilage in MCP Joints in Early Rheumatoid Arthritis 2010
Under Utilization of DMARDs in Early Rheumatoid Arthritis: A Population-Based Study from the Ontario Biologics Research Initiative Comparing Rheumatology Care with Primary Care 2010
Use of Oral Contraceptive Pills in Patients with SLE - A Survey of Rheumtologists in Canada 2010
Utility and feasibility of musculoskeletal ultrasonography (MSK US) in rheumatology practice in Canada: Needs assessment 2010
Von Willebrand Factor Antigen - A Novel Biomarker of Disease Activity in Childhood CNS Vasculitis 2010
A Cross-Sectional Study on the Relation Between Clinical Characteristics and MRI Findings in the Hands of Rheumatoid Arthritis Patients - Preliminary Results 2009
An Evaluation of the Potential Effects of a National Consensus Statement on Optimal Treatment of Early Rheumatoid Arthritis in Ontario 2009
Assessment of Fracture Risk and Treatment of Osteoporosis in Postmenopausal Women: Bone Density vs. BONE DESTINY (c) 2009
Baseline Characteristics of Patients Receiving Biologic and DMARD Therapy in Ontario: Results from the Ontario Biologics Research Initiative 2009
Continued Inhibition of Structural Damage in Rheumatoid Arthritis Patients Treated with Rituximab at 2 Years: REFLEX Study 2009
Medication Exposures and Serious Infections in a Population-based Cohort of Older Individuals with Rheumatoid Arthritis (RA) 2009
Patients with Fragility Fracture Assessed by BMD, BONE DESTINY (c) and Osteoporosis Canada Guidelines 2009
Patients with Rheumatoid Arthritis Achieve a Rapid Response When Treated with Certolizumab Pegol Irrespective of Background Treatment 2009
Serious Infections in a Population-based Cohort of Older Individuals with Rheumatoid Arthritis 2009
Successful Clinical Outcomes in Canadian Early Inflammatory Arthritis Patients: Data from the CATCH Study 2009
Ultrasound of the Hands and Feet: Effect on Rheumatologists' Diagnostic Confidence and Patient Management 2009
Use of Biologic Response Modifying Drugs by Ontario Rheumatology Specialists: 2008 Update 2009
Variation in Outcome Measures in Hip and Knee Arthroplasty Clinical Trials: A Proposed Approach to Achieving Consensus 2009
A qualitative study to determine best methods for post-marketing surveillance in usual rheumatology care in Ontario 2008
Adherence to guidelines for the detection of pulmonary hypertension in patients with scleroderma 2008
CNS Wegener's granulomatosis presenting with Bell's palsy 2008
Efficacy of bazedoxifene for the prevention of postmenopausal osteoporosis: Results of a 2-year, phase III, placebo- and active-controlled study 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial 2008
Factors associated with physician service use in systemic sclerosis 2008
GALS exam identifies musculoskeletal abnormalities not previously identified in routine family practice 2008
Holding me back: Living with arthritis while recovering from a stroke 2008
Impact of a training video on learning the GALS screening examination in medical students 2008
Impact of a video on learning the GALS musculoskeletal screening exam in medical students 2008
Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors 2008
MRI evaluation of scalp artery inflammation in patients with giant cell arteritis 2008
Oncogenic osteomalacia. A case report and literature review 2008
Oral contraceptives and systemic lupus erythematosus, current practice in Hamilton 2008
Osteoporosis prophylaxis in rheumatoid arthritis patients 2008
Resident evaluations: The use of evaluation cards in rheumatology ambulatory care 2008
Wegener's granulomatosis - Analysis of the Hamilton inpatient experience 2008
Corticosteroids in chikungunya viral polyarthritis in two Canadian travelers 2007
Efficacy and safety of adalimumab (Humira (R)) in Canadian clinical practice: Results from the canact trial 2007
Efficacy of adalimumab (Humira (R)) in Canadian clinical practice: Subanalysis of the canact trial for patients with moderate vs. severe rheumatoid arthritis 2007
Prolonged efficacy of rituximab in rheumatoid arthritis patients and inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (reflex study) 2007
Rituximab improves health-related quality of life as measured by the SF-36: Domain score results from the reflex study 2007
Smoldering RA: Is the Canadian health care system neglecting a significant disease population? 2007
Transition to electronic medical records: What rheumatologists need to know. 2007
Use of biologic response modifying drugs by Ontario rheumatology specialists. 2007
Development of the effective musculoskeletal consumer scale. 2007
Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre Osteoporosis Study (CaMOS). 2006
Predictors of osteoporosis diagnosis among patients with fragility hip fracture 2006
Reliability of exercise testing parameters in children with juvenile idiopathic arthritis (JIA) 2006
Reliability of functional activity questionnaires in children with juvenile idiopathic arthritis (JIA) 2006
The effects of vigorous exercise training on motor function and functional fitness in children with juvenile idiopathic arthritis (JIA) 2006
The role of immunodulatory agents in the prediction of mortality in an inception cohort of patients with systemic lupus erythematosus (SLE) 2006
Time-dependent analyses of lipid abnormalities as risk factors for renal deterioration in systemic lupus erythematosus 2006
A pilot study on the measurement and determinants of the Quality of Life (QOL) in pediatric rheumatology patients 2005
Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The CanACT and the ReACT trial 2005
Rheumatology nurse training and standardization in rheumatoid arthritis disease activity assessment 2005
Characteristics that predict new fragility non-vertebral fracture in postmenopausal women who are enrolled in the Canadian Multicentre Osteoporosis Study (CaMos) 2004
Hydroxychloroquine is associated with lower risk of thrombotic event in a longitudinal observational cohort. 2004
Participant characteristics of postmenopausal women that predict new clinically recognized vertebral fracture in a three-year observational study: The Canadian Multicentre Osteoporosis Study (CAMOS). 2004
Rapid resolution of the reduction of bone turnover markers after discontinuation of risedronate in postmenopausal women with osteoporosis previously treated for 2 years. 2004
Responsiveness of four performance measures used to evaluate outcome following total hip and knee arthroplasty 2004
The incidence rate of thrombosis after diagnosis of systemic lupus erythematosus follows a bimodal pattern. 2004
An assessment of safety of daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patients with rheumatoid arthritis (RA) 2003
Assessment of changes in patient function, measured by the health assessment questionnaire - Disability index (HAQ-DI), following daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patents with rheumatoid arthritis (RA) 2003
Frequency and characteristics of autoantibodies in rheumatoid arthritis (RA) and their relationship to disease duration: Results of two large Etanercept trials 2003
Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: A comparative review 2003
Measuring disease activity in systemic onset JIA 2003
Nonvertebral fracture risk is significantly reduced with risedronate treatment in just one year 2003
Once-a-week risedronate is effective in reducing vertebral fracture risk 2003
Metabolic bone disease post renal transplant - Clinical and laboratory determinants of tertiary hyperpaprathyroidism. 2002
Minimum medial joint space width reproducibility using an automated technique 2002
A randomized controlled trial evaluating effectiveness and cost-effectiveness of hylan G-F 20 in patients with knee OA 2001
Risedronate is associated with a lower incidence of gastric ulcers than alendronate: Results from two comparative studies 2001
Discrimination of changes in osteoporosis outcomes. 2001
Sjögren's syndrome: a critical review of clinical management. 1999
An interview on utility measurement. Interview by Bernie O'Brien. 1995
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2. 51:jrheum.2024-0540. 2024
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study. 51:721-727. 2024
Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry. 51:403-407. 2024
Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1. 50:1198-1199. 2023
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study. 50:965-966. 2023
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis. 50:jrheum.220261-jrheum.220261. 2023
Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs. 49:1092-1099. 2022
Healthcare Utilization and Costs for Musculoskeletal Disorders in Ontario, Canada. 49:740-747. 2022
Results From the 2020 Canadian Rheumatology Association’s Workforce and Wellness Survey. 49:635-643. 2022
Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference. 49:497-503. 2022
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. 49:447-453. 2022
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. 49:16-25. 2022
Addressing Healthcare Quality in Juvenile Idiopathic Arthritis With a Universal Access Program. 48:1635-1638. 2021
Canadian Rheumatologists’ Perspectives on Moderate Psoriatic Arthritis and Oligoarticular Psoriatic Arthritis. 48:1692-1697. 2021
Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America. 48:1616-1622. 2021
Systemic Sclerosis and Associated Interstitial Lung Disease in Ontario, Canada: An Examination of Prevalence and Survival Over 10 Years. 48:1427-1434. 2021
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic Diseases. 48:1330-1339. 2021
Feminization of the Rheumatology Workforce: A Longitudinal Evaluation of Patient Volumes, Practice Sizes, and Physician Remuneration. 48:1090-1097. 2021
Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus. 48:852-858. 2021
Esophageal Obstruction Secondary to Massive Tumoral Calcinosis. 48:786-786. 2021
CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. 48:555-566. 2021
The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis: A Randomized, Double-blind, Placebo-controlled Feasibility Study. 48:434-441. 2021
Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis. 48:228-231. 2021
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review. 47:1565-1574. 2020
Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?. 47:1366-1373. 2020
Characteristics of Takayasu Arteritis Patients with Severe Ischemic Events. 47:1224-1228. 2020
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis. 47:1001-1010. 2020
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort. 47:809-819. 2020
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA. 47:796-808. 2020
Encounters with Rheumatologists in a Publicly Funded Canadian Healthcare System: A Population-based Study. 47:468-476. 2020
Dr. Tselios, et al, reply. 46:1422.2-1422. 2019
Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. 46:874-886. 2019
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis. 46:928-934. 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary. 46:751-754. 2019
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort. 46:628-635. 2019
Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis. 46:467-474. 2019
Limited GPA and Alpha-1 Antitrypsin Deficiency in a Pediatric Patient. 46:543-544. 2019
Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?. 46:391-396. 2019
Factors Influencing the Uptake of Canadian Research Findings into the Care of Children with Arthritis: A Healthcare Provider Perspective. 46:294-300. 2019
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?. 46:64-69. 2019
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. 45:1426-1439. 2018
Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis. 45:1462-1476. 2018
Monophasic Disease Course in Systemic Lupus Erythematosus. 45:1131-1135. 2018
Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis. 45:115-121. 2018
Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise. 44:1928-1932. 2017
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study. 44:1841-1849. 2017
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group. 44:1727-1733. 2017
Nurse-led Care for Patients with Rheumatoid Arthritis: A Systematic Review of the Effect on Quality of Care. 44:757-765. 2017
The Effect of Widespread Pain on Knee Pain Worsening, Incident Knee Osteoarthritis (OA), and Incident Knee Pain: The Multicenter OA (MOST) Study. 44:493-498. 2017
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. 44:519-534. 2017
Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada. 44:248-257. 2017
Validity of the Stage of Exercise Scale in Children with Rheumatologic Conditions. 43:2189-2198. 2016
Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association. 43:1773-1776. 2016
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial. 43:1672-1679. 2016
Dr. Tselios, et al reply. 43:1767-1767. 2016
A Comparison of CAROC and FRAX in Patients with Fragility Fracture. 43:1456-1457. 2016
Adapting Knowledge Translation Strategies for Rare Rheumatic Diseases. 43:1462-1468. 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis. 43:1078-1084. 2016
Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis of Randomized Controlled Trials. 43:855-860. 2016
The Longterm Effect of Early Intensive Treatment of Seniors with Rheumatoid Arthritis: A Comparison of 2 Population-based Cohort Studies on Time to Joint Replacement Surgery. 43:861-868. 2016
How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the “Training the Rheumatologists of Tomorrow” Project. 43:788-798. 2016
Development of System-level Performance Measures for Evaluation of Models of Care for Inflammatory Arthritis in Canada. 43:530-540. 2016
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study. 43:657-665. 2016
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. 43:552-558. 2016
Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review. 43:648-656. 2016
CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides. 43:97-120. 2016
Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. 43:54-65. 2016
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort. 42:2023-2028. 2015
Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda. 42:1934-1942. 2015
Dialogue on Developing Consensus on Measurement and Presentation of Patient-important Outcomes, Using Pain Outcomes as an Exemplar, in Systematic Reviews: A Preconference Meeting at OMERACT 12. 42:1931-1933. 2015
Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop. 42:1962-1970. 2015
Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis. 42:1582-1586. 2015
Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis. 42:1392-1400. 2015
Cardiac Involvement in Granulomatosis with Polyangiitis. 42:1209-1212. 2015
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study. 42:1213-1217. 2015
Transitioning to Employment with a Rheumatic Disease: The Role of Independence, Overprotection, and Social Support. 41:2386-2394. 2014
Trying to Improve Care: The Morbidity and Mortality Conference in a Division of Rheumatology. 41:2452-2458. 2014
Earlier Time to Remission Predicts Sustained Clinical Remission in Early Rheumatoid Arthritis — Results from the Canadian Early Arthritis Cohort (CATCH). 41:2161-2166. 2014
Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects. 41:2179-2185. 2014
Immunosuppressive Therapies for the Induction Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis. 41:1998-2007. 2014
Systemic Lupus Erythematosus, Osteoporosis, and Fractures. 41:1913-1915. 2014
Osteoarthritis Incidence and Trends in Administrative Health Records from British Columbia, Canada. 41:1147-1154. 2014
Update of Strategies to Translate Evidence from Cochrane Musculoskeletal Group Systematic Reviews for Use by Various Audiences. 41:206-215. 2014
New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis. 40:1905-1912. 2013
The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review. 40:1545-1556. 2013
Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis. 40:850-858. 2013
Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis. 40:674-683. 2013
Hugh A. Smythe, 1927-2012 In Memoriam. 40:343-347. 2013
In Memoriam – Hugh A. Smythe, 1927–2012. 40:343-347. 2013
Effect of Rheumatologist Education on Systematic Measurements and Treatment Decisions in Rheumatoid Arthritis: The Metrix Study. 39:2247-2252. 2012
Increasing Treatment in Early Rheumatoid Arthritis Is Not Determined by the Disease Activity Score But by Physician Global Assessment: Results from the CATCH Study. 39:2081-2087. 2012
Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab. 39:2227-2229. 2012
Longitudinal Study of Renal Function in Systemic Sclerosis. 39:1829-1834. 2012
Amyloidosis and Giant Cell Arteritis/Polymyalgia Rheumatica. 39:878-880. 2012
Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Patients with Systemic Sclerosis. 39:787-794. 2012
Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group. 39:524-531. 2012
Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis. 39:303-309. 2012
Atypical Femoral Fractures in Patients Taking Longterm Alendronate. 38:2686-2687. 2011
Measuring Pain in Systemic Sclerosis: Comparison of the Short-form McGill Pain Questionnaire Versus a Single-item Measure of Pain. 38:2581-2587. 2011
Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis. 38:1622-1630. 2011
Antiphospholipid Syndrome and the Aorta: A Rare Presentation. 38:1808-1809. 2011
Posterior Reversible Encephalopathy Syndrome: Increasing Recognition of an Important Clinical Entity in Young Patients with Systemic Lupus Erythematosus. 38:1544-1545. 2011
Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons. 38:1396-1402. 2011
ANCA-associated Vasculitides and Classification: A Conundrum Solved?. 38:971-972. 2011
Thrombovascular Events Affect Quality of Life in Patients with Systemic Lupus Erythematosus. 38:1017-1019. 2011
Predictors of Hip Disease in the Systemic Arthritis Subtype of Juvenile Idiopathic Arthritis. 38:954-958. 2011
Disability in Systemic Sclerosis — A Longitudinal Observational Study. 38:685-692. 2011
Observational Data to Study Medication Outcomes in Systemic Sclerosis: Table 1.. 38:575.2-577. 2011
Botulinum Toxin Intramuscular Injections for Neck Pain: A Systematic Review and Metaanalysis. 38:203-214. 2011
Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis. 38:69-78. 2011
Quantitative Power Doppler Ultrasonography Is a Sensitive Measure of Metacarpophalangeal Joint Synovial Vascularity in Rheumatoid Arthritis and Declines Significantly Following a 2-week Course of Oral Low-dose Corticosteroids. 37:2493-2501. 2010
Toward Standardized Ultrasound Measurements of Cartilage Thickness in Children: Figure 1.. 37:2445-2447. 2010
Discordance between Patient and Physician Assessments of Disease Severity in Systemic Sclerosis. 37:2307-2312. 2010
The Association Between Disease Activity and Duration in Systemic Sclerosis. 37:2299-2306. 2010
Correction: Oral Contraceptives and Systemic Lupus Erythematosus, Current Practice in Hamilton. 37:1788.2-1788. 2010
Dr. Adachi and Dr. Lau reply. 37:676.1-676. 2010
The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma. 37:591-598. 2010
Assessment of the Methodologic Quality of Medical and Surgical Clinical Trials in Patients with Arthroplasty. 36:2642-2654. 2009
Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database. 36:2737-2743. 2009
Catastrophic Antiphospholipid Syndrome and Polyarteritis Nodosa. 36:2619-2621. 2009
Work Disability in Systemic Sclerosis. 36:2481-2486. 2009
How to Ascertain Drug Safety in the Context of Benefit. Controversies and Concerns: Table 1.. 36:2114-2121. 2009
Responsiveness of the Effective Consumer Scale (EC-17). 36:2087-2091. 2009
Variation in Outcome Measures in Hip and Knee Arthroplasty Clinical Trials: A Proposed Approach to Achieving Consensus. 36:2050-2056. 2009
Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy. 36:1835-1837. 2009
Validity of Self-Reported Comorbidities in Systemic Sclerosis: Table 1.. 36:1477-1480. 2009
Effect of Musculoskeletal Pain on Sexuality of Male Adolescents and Adults with Juvenile Idiopathic Arthritis. 36:1337-1342. 2009
Resident Evaluations: The Use of Daily Evaluation Forms in Rheumatology Ambulatory Care. 36:1298-1303. 2009
Bisphosphonate Associated Osteonecrosis of the Jaw. 36:478-490. 2009
The Challenges of Developing Online Learning. 36:470-471. 2009
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.. 36:279-287. 2009
Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis. 36:96-98. 2009
Raynaud’s Phenomenon as a Presenting Feature of Hypothyroidism in an 11-year-old Girl. 36:203-203. 2009
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw (Journal of Rheumatology (2008) 35, (1391-1397)). 35:2084. 2008
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw (Journal of Rheumatology (2008) 35, (1391-1397)). 35:1688. 2008
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw (vol 35, pg 1391, 2008). 35:1688-1688. 2008
Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?. 35:1506-1512. 2008
Understanding social role participation: what matters to people with arthritis?. 35:1655-1663. 2008
Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.. 35:1391-1397. 2008
Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.. 35:1073-1078. 2008
Chikungunya viral polyarthritis.. 35:935-936. 2008
Churg-Strauss syndrome and revascularization of the hand: a case report.. 35:941-943. 2008
Osteonecrosis of the jaw: new developments in an old disease.. 35:547-549. 2008
Hypocomplementemia in systemic sclerosis--clinical and serological correlations.. 34:2218-2223. 2007
Validation of the Comprehensive ICF Core Set for Osteoarthritis (OA) in patients with knee OA: a Singaporean perspective.. 34:2301-2307. 2007
Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.. 34:2112-2119. 2007
Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis.. 34:1802-1809. 2007
A review of the sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised sapporo criteria add value?. 34:1522-1527. 2007
Extremity magnetic resonance imaging.. 34:1634-1635. 2007
Gross, et al reply [4]. 34:1635-1636. 2007
Levels of evidence for epidural steroid injections. 34:1635-1636. 2007
Conservative management of mechanical neck disorders: a systematic review.. 34:1083-1102. 2007
Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.. 34:992-996. 2007
A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.. 34:534-542. 2007
Direct and indirect costs of OA in Singapore: A comparative study among multiethnic Asian patients. 34:165-171. 2007
Effect of therapeutic exercise and sleeping neck support on patients with chronic neck pain: a randomized clinical trial.. 34:151-158. 2007
Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.. 33:2199-2213. 2006
Knowledge transfer to clinicians and consumers by the Cochrane Musculoskeletal Group.. 33:2312-2318. 2006
Method guidelines for Cochrane Musculoskeletal Group systematic reviews.. 33:2304-2311. 2006
Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.. 33:2222-2226. 2006
Medicinal and injection therapies for mechanical neck disorders: a Cochrane systematic review.. 33:957-967. 2006
Community-based evaluation of etanercept in patients with rheumatoid arthritis.. 33:665-670. 2006
Attributes and skills of an effective musculoskeletal consumer.. 32:2257-2261. 2005
Thrombosis and inflammation: a question in need of an answer.. 32:397-399. 2005
Matrix catabolism in arthritis: priming the guns with oncostatin M.. 31:2326-2328. 2004
Are there differences between men and women prescribed bisphosphonate therapy in canadian subspecialty osteoporosis practices?. 31:1993-1995. 2004
Antiphospholipid antibody syndrome: further evidence to guide clinical practice?. 31:1474-1475. 2004
Resource utilization in postmenopausal osteoporosis without incident fractures.. 31:938-942. 2004
CANDOO and CANOAR, CORRONA and more: advancing therapeutics through layered-in clinical data collection and feedback at the point of care.. 30:2308-2311. 2003
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus.. 30:1011-1016. 2003
How "soft" are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus.. 30:1006-1010. 2003
The effects of exercise and education, individually or combined, in women with fibromyalgia.. 29:2620-2627. 2002
14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.. 29:1965-1974. 2002
Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.. 29:1110-1111. 2002
Predictors of success of intervention programs for persons with fibromyalgia.. 29:1034-1040. 2002
Living with lupus: a prospective pan-Canadian study.. 28:2442-2448. 2001
Clinical improvement in osteoarthritis.. 28:1932. 2001
Low back pain: prevalence and risk factors in an industrial setting.. 28:346-351. 2001
A community rheumatology practice offers an educational experience comparable to that of a university tertiary care center.. 27:2903-2905. 2000
Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study.. 27:2671-2676. 2000
A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.. 27:2424-2431. 2000
Does strengthening the abdominal muscles prevent low back pain? Reply. 27:2287-2288. 2000
A comparison study of the back pain functional scale and Roland Morris Questionnaire. North American Orthopaedic Rehabilitation Research Network.. 27:1928-1936. 2000
A comparison study of the back pain functional scale and Roland Morris questionnaire. 27:1928-1936. 2000
A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists.. 27:1506-1512. 2000
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.. 27:623-629. 2000
Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer.. 27:582-588. 2000
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.. 27:373-376. 2000
Validity and reliability of the 6 minute walk in persons with fibromyalgia.. 26:2233-2237. 1999
Does strengthening the abdominal muscles prevent low back pain--a randomized controlled trial.. 26:1808-1815. 1999
36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.. 26:1545-1549. 1999
A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.. 26:1148-1157. 1999
Defining morning stiffness in rheumatoid arthritis.. 26:1052-1057. 1999
Does smoking cause rheumatoid arthritis?. 26:1-3. 1999
Responsiveness of endpoints in osteoporosis clinical trials--an update.. 26:222-228. 1999
Determinants of disability after a work related musculetal injury.. 25:1570-1577. 1998
The relationship between strength and function in females with juvenile rheumatoid arthritis.. 25:1399-1405. 1998
The pyramids of rheumatoid arthritis - Reply. 25:819-819. 1998
Back to the future: The pyramids of rheumatoid arthritis - reply. 25:602-602. 1998
A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis.. 25:231-237. 1998
Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.. 24:2308-2313. 1997
Assessment of sexual function in patients with rheumatic disorders: a critical appraisal.. 24:1673-1676. 1997
Health state utilities in knee replacement surgery: the development and evaluation of McKnee.. 24:1796-1805. 1997
Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.. 24:1324-1331. 1997
Polymyositis in a patient with thymoma and T cell lymphocytosis.. 24:1413-1416. 1997
Back to the future: the pyramids of rheumatoid arthritis.. 24:1023-1027. 1997
Guidelines for osteoporosis trials.. 24:1234-1236. 1997
Osteoporosis clinical trials endpoints: candidate variables and clinimetric properties.. 24:1222-1229. 1997
Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report.. 24:998-1003. 1997
Prevention of corticosteroid induced osteoporosis.. 24:407. 1997
Community screening for rheumatic disorder: Cross cultural adaptation and screening characteristics of the COPCORD core questionnaire in Brazil, Chile, and Mexico. 24:160-168. 1997
Community screening for rheumatic disorder: cross cultural adaptation and screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. The PANLAR-COPCORD Working Group. Pan American League of Associations for Rheumatology. Community Oriented Programme for the Control of Rheumatic Disease.. 24:160-168. 1997
Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group.. 23:1953-1955. 1996
Systemic lupus international collaborating clinics conference on assessment of lupus flare and quality of life measures in SLE. 23:1953-1955. 1996
The importance of community based epidemiological studies.. 23:1500-1501. 1996
Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.. 23:1579-1585. 1996
The Juvenile Arthritis Functional Status Index (JASI): a validation study.. 23:1066-1079. 1996
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.. 23:995-1000. 1996
Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro.. 23:862-868. 1996
Clinically important change in rheumatoid arthritis - Reply. 23:786-788. 1996
The fibromyalgia syndrome: a consensus report on fibromyalgia and disability.. 23:534-539. 1996
Isometric strength measurements of knee extensors in women with osteoarthritis of the knee.. 23:328-331. 1996
INTERACTIVE CONFERENCE VOTING. 22:1420-1430. 1995
Interactive conference voting. The OMERACT II Committee. Outcome Measures in Rheumatoid Arthritis Clinical Trial Conference.. 22:1420-1430. 1995
A taxonomy of health status instruments.. 22:1188-1190. 1995
Cognitive dysfunction in systemic lupus erythematosus is independent of active disease.. 22:863-867. 1995
The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls.. 22:944-952. 1995
SALSALATE, A NONACETYLATED SALICYLATE, IS AS EFFICACIOUS AS DICLOFENAC IN PATIENTS WITH RHEUMATOID-ARTHRITIS. 22:617-624. 1995
Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group.. 22:617-624. 1995
Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).. 21:2034-2038. 1994
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.. 21:1922-1926. 1994
Inflammatory myopathy--do we have adequate measures of the treatment response?. 21:1775. 1994
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.. 21:1468-1471. 1994
Development of a self-report functional status index for juvenile rheumatoid arthritis.. 21:536-544. 1994
Interrater reliability of the tender point criterion for fibromyalgia.. 21:370-371. 1994
The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--an 8-month followup.. 21:261-263. 1994
Can specially trained physiotherapists improve the care of patients with rheumatoid arthritis? A randomized health care trial.. 21:70-79. 1994
A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis.. 20:2095-2103. 1993
Measuring abdominal muscle weakness in patients with low back pain and matched controls: a comparison of 3 devices.. 20:1539-1543. 1993
Modelling the population health impact of musculoskeletal diseases: arthritis.. 20:1037-1047. 1993
The population health impact of arthritis. POHEM Workshop Group.. 20:1048-1051. 1993
A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus.. 20:657-660. 1993
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.. 20:561-565. 1993
Interpretation and power of a pooled index.. 20:575-578. 1993
Pooled outcome measures in arthritis: the pros and cons.. 20:566-567. 1993
Interrater reliability of the tender point criterion for fibromyalgia.. 19:1955-1959. 1992
Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus.. 19:1820-1821. 1992
Physical disability among Canadians reporting musculoskeletal diseases.. 19:1020-1030. 1992
Synoviocyte derived granulocyte macrophage colony stimulating factor mediates the survival of human lymphocytes.. 19:1065-1069. 1992
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.. 19:608-611. 1992
Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.. 19:534-537. 1992
Challenges in designing antirheumatic drug trials.. 18:1643-1644. 1991
Markers of bone turnover in rheumatoid arthritis.. 18:1119-1120. 1991
Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation.. 18:661-665. 1991
Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials.. 18:447-451. 1991
Meta-analysis of sulfasalazine in ankylosing spondylitis.. 17:1482-1486. 1990
Lymphoma presenting as a popliteal mass in a patient with rheumatoid arthritis.. 17:1242-1243. 1990
Responses of the colonic epithelium to auranofin: evidence for involvement of enteric nerves.. 17:1137-1141. 1990
Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis.. 17:1022-1024. 1990
Remodelling the pyramid: the therapeutic target of rheumatoid arthritis.. 17:987-989. 1990
An evaluation of four different measures of abdominal muscle strength: patient, order and instrument variation.. 17:965-969. 1990
Bone densitometry.. 17:419-420. 1990
The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--a randomized controlled trial.. 17:228-233. 1990
Criteria for assessing disease activity in systemic lupus erythematosus.. 16:1395-1396. 1989
PULSE STEROID-THERAPY, RHEUMATOID-ARTHRITIS AND THE JOURNAL-OF-RHEUMATOLOGY - REPLY. 15:1873-1873. 1988
Pauciarticular juvenile rheumatoid arthritis presenting in an adult.. 15:1865-1867. 1988
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.. 15:1833-1840. 1988
Late onset gold induced thrombocytopenia.. 15:1450-1451. 1988
An experiment in reducing interobserver variability of the examination for joint tenderness.. 15:492-494. 1988
Pulse steroid therapy and the search for improved drug therapy of rheumatoid arthritis.. 15:200-201. 1988
Low dose cyclosporine in rheumatoid arthritis: a pilot study.. 14:1108-1114. 1987
Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.. 14:740-744. 1987
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis.. 14:446-451. 1987
The total assessment of rheumatoid polyarthritis--evaluation of a training program for physiotherapists and occupational therapists.. 14:87-92. 1987
A shorter plasma half life does not predict less drug accumulation.. 13:1185-1186. 1986
Lowering of plasma isoxicam concentrations with acetylsalicylic acid.. 13:1119-1121. 1986
Patient, observer and instrument variation in the measurement of strength of shoulder abductor muscles in patients with rheumatoid arthritis using a modified sphygmomanometer.. 13:1044-1049. 1986
HLA TYPING, PLATELET ASSOCIATED IMMUNOGLOBULINS AND ANTICARDIOLIPIN ANTIBODY - REPLY. 13:989-990. 1986
OBSERVER VARIATION AND THE RITCHIE ARTICULAR INDEX - REPLY. 13:836-837. 1986
GOLD INDUCED THROMBOCYTOPENIA - REPLY. 13:227-227. 1986
Epidemiology of musculoskeletal disorders (complaints) and related disability in Canada.. 12:1169-1173. 1985
Gold induced aplastic anemia.. 12:1011-1012. 1985
Mathematical modelling of pathogenesis and treatment: new insights into old questions.. 12:824-828. 1985
A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.. 12:724-727. 1985
Grading of tenderness as a source of interrater error in the Ritchie articular index.. 12:716-717. 1985
The lupus activity criteria count (LACC).. 11:783-787. 1984
Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.. 11:457-461. 1984
Measurements of spinal mobility in the sagittal plane: new skin contraction technique compared with established methods.. 11:507-511. 1984
Sympathetic synovial effusion associated with septic prepatellar bursitis: synovial fluid analysis with therapeutic implications.. 11:555-556. 1984
Gold induced thrombocytopenia: platelet associated IgG and HLA typing in three patients.. 11:355-357. 1984
Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.. 10:136-139. 1983
Independent measurement of functional capacity in rheumatoid arthritis.. 9:794-797. 1982
Selection and combination of outcome measures.. 9:770-774. 1982
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease.. 9:780-784. 1982
On the critical assessment and clinical applicability of the rheumatology literature.. 7:765-771. 1980
Reversal of hypertrophic osteoarthropathy after chemotherapy for bronchogenic carcinoma.. 7:93-97. 1980
"Independent assessor" and "pooled index" as techniques for measuring treatment effects in rheumatoid arthritis.. 4:144-152. 1977
The arthritic complaint in primary care: prevalence, related disability, and costs.. 3:88-99. 1976

Journal of Rheumatology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)